Bioprosthetic Aortic Valve Replacement in <50 Years Old Patients – Where is the Evidence?
AUTOR(ES)
Harky, Amer
FONTE
Braz. J. Cardiovasc. Surg.
DATA DE PUBLICAÇÃO
20/05/2019
RESUMO
Abstract Aortic valve disease is one of the most common valvular heart diseases in the cardiovascular category. Surgical replacement of the diseased aortic valve remains the definitive intervention for most diseases. There is a clear consensus that in young patients who require aortic valve replacement, a mechanical prosthesis is the preferred choice due to its durable prosthesis without fear of wear and tear over time. However, this comes at the expense of increased risk of bleeding and thromboembolic events; in addition, there is a lack of strict evidence in using bioprosthesis in patients younger than 50 years. The objective of this review article is to assess the current evidence behind using bioprosthetic aortic valve in this young cohort.
Documentos Relacionados
- Comparison of Postoperative Outcomes of Sutureless versus Stented Bioprosthetic Aortic Valve Replacement
- Primary care counselling for injury prevention: where is the evidence?
- Aortic valve replacement in elderly patients with aortic stenosis.
- Clinical Results After Bioprosthetic Aortic Valve Replacement in Patients With and Without Coronary Artery Disease: Value of Concomitant Myocardial Revascularization *
- Comparison of Transcatheter Aortic Valve Implantationversus Surgical Aortic Valve Replacement to Improve Quality of Life in Patients >70 Years of Age with Severe Aortic Stenosis